{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T08:09:33Z","timestamp":1795075773130,"version":"4.10.2"},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Over the past few years, mesenchymal stromal cells (MSCs) have attracted a great deal of scientific attention owing to their promising results in the treatment of incurable diseases. However, there are several concerns about their possible side effects after direct cell transplantation, including host immune response, time-consuming cell culture procedures, and the dependence of cell quality on the donor, which limit the application of MSCs in clinical trials. On the other hand, it is well accepted that the beneficial effects of MSCs are mediated by secretome rather than cell replacement. MSC secretome refers to a variety of bioactive molecules involved in different biological processes, specifically neuro-regeneration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>Due to the limited ability of the central nervous system to compensate for neuronal loss and relieve disease progress, mesenchymal stem cell products may be used as a potential cure for central nervous system disorders. In the present study, the therapeutic effects of MSC secretome were reviewed and discussed the possible mechanisms in the three most prevalent central nervous system disorders, namely Alzheimer's disease, multiple sclerosis, and Parkinson's disease. The current work aimed to help discover new medicine for the mentioned complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The use of MSC-derived secretomes in the treatment of the mentioned diseases has encouraging results, so it can be considered as a treatment option for which no treatment has been introduced so far.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-023-03264-0","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T15:01:42Z","timestamp":1683212502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials"],"prefix":"10.1186","volume":"14","author":[{"given":"Maryam","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Roshandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhdeh","family":"Mohammadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrouz","family":"Farhadihosseinabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Akbarzadehlaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-857X","authenticated-orcid":false,"given":"Karim","family":"Shamsasenjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"issue":"1","key":"3264_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P. Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med. 2020;36(1):1\u201312.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"3264_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"D Twohig","year":"2019","unstructured":"Twohig D, Nielsen HM. \u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14(1):1\u201319.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"3264_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.neurol.2018.03.006","volume":"174","author":"H Z\u00e9phir","year":"2018","unstructured":"Z\u00e9phir H. Progress in understanding the pathophysiology of multiple sclerosis. Revue Neurol. 2018;174(6):358\u201363.","journal-title":"Revue Neurol"},{"issue":"4","key":"3264_CR4","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1007\/s11033-020-05354-1","volume":"47","author":"E Singh","year":"2020","unstructured":"Singh E, Devasahayam G. Neurodegeneration by oxidative stress: a review on prospective use of small molecules for neuroprotection. Mol Biol Rep. 2020;47(4):3133\u201340.","journal-title":"Mol Biol Rep"},{"key":"3264_CR5","doi-asserted-by":"publisher","first-page":"107523","DOI":"10.1016\/j.pharmthera.2020.107523","volume":"210","author":"LG Costa","year":"2020","unstructured":"Costa LG, Cole TB, Dao K, Chang Y-C, Coburn J, Garrick JM. Effects of air pollution on the nervous system and its possible role in neurodevelopmental and neurodegenerative disorders. Pharmacol Ther. 2020;210:107523.","journal-title":"Pharmacol Ther"},{"key":"3264_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pharmthera.2017.08.010","volume":"182","author":"JG Choi","year":"2018","unstructured":"Choi JG, Kim SY, Jeong M, Oh MS. Pharmacotherapeutic potential of ginger and its compounds in age-related neurological disorders. Pharmacol Ther. 2018;182:56\u201369.","journal-title":"Pharmacol Ther"},{"key":"3264_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.bbi.2020.10.024","volume":"91","author":"A Zimmer","year":"2021","unstructured":"Zimmer A, Youngblood A, Adnane A, Miller BJ, Goldsmith DR. Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: a review of the literature and recommendations for the COVID-19 pandemic. Brain Behav Immun. 2021;91:756\u201370.","journal-title":"Brain Behav Immun"},{"key":"3264_CR8","doi-asserted-by":"publisher","first-page":"152299","DOI":"10.1016\/j.tox.2019.152299","volume":"428","author":"J Khan","year":"2019","unstructured":"Khan J, Salhotra S, Goswami P, Akhter J, Jahan S, Gupta S, et al. Bisphenol A triggers axonal injury and myelin degeneration with concomitant neurobehavioral toxicity in C57BL\/6J male mice. Toxicology. 2019;428:152299.","journal-title":"Toxicology"},{"issue":"3","key":"3264_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/ars.2020.8076","volume":"33","author":"C Cervellati","year":"2020","unstructured":"Cervellati C, Trentini A, Pecorelli A, Valacchi G. Inflammation in neurological disorders: the thin boundary between brain and periphery. Antioxid Redox Signal. 2020;33(3):191\u2013210.","journal-title":"Antioxid Redox Signal"},{"key":"3264_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.pathol.1.110304.100113","volume":"1","author":"DM Skovronsky","year":"2006","unstructured":"Skovronsky DM, Lee VMY, Trojanowski JQ. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol Mech Dis. 2006;1:151\u201370.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"10","key":"3264_CR11","doi-asserted-by":"publisher","first-page":"6978","DOI":"10.1021\/acs.inorgchem.0c00467","volume":"59","author":"AI Matesanz","year":"2020","unstructured":"Matesanz AI, Caballero AB, Lorenzo C, Espargaro A, Sabat\u00e9 R, Quiroga AG, et al. Thiosemicarbazone derivatives as inhibitors of amyloid-\u03b2 aggregation: effect of metal coordination. Inorg Chem. 2020;59(10):6978\u201387.","journal-title":"Inorg Chem"},{"issue":"1","key":"3264_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3(1):1\u201321.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"3264_CR13","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10072-016-2625-7","volume":"37","author":"A Kulshreshtha","year":"2016","unstructured":"Kulshreshtha A, Piplani P. Current pharmacotherapy and putative disease-modifying therapy for Alzheimer\u2019s disease. Neurol Sci. 2016;37(9):1403\u201335.","journal-title":"Neurol Sci"},{"key":"3264_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s40261-021-01011-y","volume":"41","author":"R Giossi","year":"2021","unstructured":"Giossi R, Carrara F, Mazzari M, Re FL, Senatore M, Schicchi A, et al. Overall efficacy and safety of safinamide in Parkinson\u2019s disease: a systematic review and a meta-analysis. Clin Drug Investig. 2021;41:321\u201339.","journal-title":"Clin Drug Investig"},{"issue":"18","key":"3264_CR15","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1016\/j.bmcl.2017.07.075","volume":"27","author":"JM Ellis","year":"2017","unstructured":"Ellis JM, Fell MJ. Current approaches to the treatment of Parkinson\u2019s disease. Bioorg Med Chem Lett. 2017;27(18):4247\u201355.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"3264_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis\u2013a review. Eur J Neurol. 2019;26(1):27\u201340.","journal-title":"Eur J Neurol"},{"issue":"4","key":"3264_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1352458517703802","volume":"24","author":"JA Cohen","year":"2018","unstructured":"Cohen JA, Imrey PB, Planchon SM, Bermel RA, Fisher E, Fox RJ, et al. Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. Mult Scler J. 2018;24(4):501\u201311.","journal-title":"Mult Scler J"},{"issue":"10076","key":"3264_CR18","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0140-6736(16)32388-1","volume":"389","author":"G Comi","year":"2017","unstructured":"Comi G, Radaelli M, Soelberg SP. Evolving concepts in the treatment of relapsing multiple sclerosis. Lancet. 2017;389(10076):1347\u201356.","journal-title":"Lancet"},{"issue":"12","key":"3264_CR19","doi-asserted-by":"publisher","first-page":"9230","DOI":"10.1002\/jcp.29810","volume":"235","author":"H Abbaszadeh","year":"2020","unstructured":"Abbaszadeh H, Ghorbani F, Derakhshani M, Movassaghpour AA, Yousefi M, Talebi M, et al. Regenerative potential of Wharton\u2019s jelly-derived mesenchymal stem cells: a new horizon of stem cell therapy. J Cell Physiol. 2020;235(12):9230\u201340.","journal-title":"J Cell Physiol"},{"issue":"6","key":"3264_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2174\/1574888X12666170502095625","volume":"12","author":"C Viswanathan","year":"2017","unstructured":"Viswanathan C, Kulkarni R, Bopardikar A, Ramdasi S. Significance of CD34 negative hematopoietic stem cells and CD34 positive mesenchymal stem cells\u2013a valuable dimension to the current understanding. Curr Stem Cell Res Ther. 2017;12(6):476\u201383.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"9","key":"3264_CR21","first-page":"1109","volume":"28","author":"C-SS Lin","year":"2013","unstructured":"Lin C-SS, Xin Z-CC, Dai J, Lue TF. Commonly used mesenchymal stem cell markers and tracking labels: limitations and challenges. Histol Histopathol. 2013;28(9):1109.","journal-title":"Histol Histopathol"},{"issue":"3","key":"3264_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.15171\/apb.2015.041","volume":"5","author":"N Hashemi Goradel","year":"2015","unstructured":"Hashemi Goradel N, Darabi M, Shamsasenjan K, Ejtehadifar M, Zahedi S. Methods of liver stem cell therapy in rodents as models of human liver regeneration in hepatic failure. Adv Pharm Bull. 2015;5(3):293\u20138.","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"3264_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-61167-z","volume":"10","author":"Y Petrenko","year":"2020","unstructured":"Petrenko Y, Vackova I, Kekulova K, Chudickova M, Koci Z, Turnovcova K, et al. A comparative analysis of multipotent mesenchymal stromal cells derived from different sources, with a focus on neuroregenerative potential. Sci Rep. 2020;10(1):1\u201315.","journal-title":"Sci Rep"},{"issue":"2","key":"3264_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00018-019-03268-1","volume":"77","author":"SA Mathew","year":"2020","unstructured":"Mathew SA, Naik C, Cahill PA, Bhonde RR. Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesis. Cell Mol Life Sci. 2020;77(2):253\u201365.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"3264_CR25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915X689622","volume":"25","author":"T Squillaro","year":"2016","unstructured":"Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25(5):829\u201348.","journal-title":"Cell Transplant"},{"issue":"17","key":"3264_CR26","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1007\/s00018-016-2229-7","volume":"73","author":"M Mo","year":"2016","unstructured":"Mo M, Wang S, Zhou Y, Li H, Wu Y. Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential. Cell Mol Life Sci. 2016;73(17):3311\u201321.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"3264_CR27","first-page":"433","volume":"3","author":"M Mohammadian","year":"2013","unstructured":"Mohammadian M, Shamsasenjan K, Lotfi Nezhad P, Talebi M, Jahedi M, Nickkhah H, et al. Mesenchymal stem cells: new aspect in cell-based regenerative therapy. Adv Pharm Bull. 2013;3(2):433\u20137.","journal-title":"Adv Pharm Bull"},{"issue":"4","key":"3264_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.15171\/apb.2017.065","volume":"7","author":"H Timari","year":"2017","unstructured":"Timari H, Shamsasenjan K, Movassaghpour A, Akbarzadehlaleh P, Pashoutan Sarvar D, Aqmasheh S. The effect of mesenchymal stem cell-derived extracellular vesicles on hematopoietic stem cells fate. Adv Pharm Bull. 2017;7(4):531\u201346.","journal-title":"Adv Pharm Bull"},{"key":"3264_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8822579","author":"M Yang","year":"2020","unstructured":"Yang M, Sun W, Xiao L, He M, Gu Y, Yang T. Mesenchymal stromal cells suppress hippocampal neuron autophagy stress induced by hypoxic-ischemic brain damage: the possible role of endogenous IL-6 secretion. Neural Plast. 2020. https:\/\/doi.org\/10.1155\/2020\/8822579.","journal-title":"Neural Plast"},{"issue":"4","key":"3264_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.5966\/sctm.2015-0161","volume":"5","author":"G Pach\u00f3n-Pe\u00f1a","year":"2016","unstructured":"Pach\u00f3n-Pe\u00f1a G, Serena C, Ejarque M, Petriz J, Duran X, Oliva-Olivera W, et al. Obesity determines the immunophenotypic profile and functional characteristics of human mesenchymal stem cells from adipose tissue. Stem Cells Transl Med. 2016;5(4):464\u201375.","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"3264_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3727\/096368916X693716","volume":"26","author":"E Sykov\u00e1","year":"2017","unstructured":"Sykov\u00e1 E, Rychmach P, Drahor\u00e1dov\u00e1 I, Konr\u00e1dov\u00e1 \u0160, R\u016f\u017ei\u010dkov\u00e1 K, Vo\u0159\u00ed\u0161ek I, et al. Transplantation of mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: results of phase I\/IIa clinical trial. Cell Transplant. 2017;26(4):647\u201358.","journal-title":"Cell Transplant"},{"issue":"15","key":"3264_CR32","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1089\/scd.2016.0020","volume":"25","author":"P Abramowski","year":"2016","unstructured":"Abramowski P, Krasemann S, Ernst T, Lange C, Ittrich H, Schweizer M, et al. Mesenchymal stromal\/stem cells do not ameliorate experimental autoimmune encephalomyelitis and are not detectable in the central nervous system of transplanted mice. Stem Cells Dev. 2016;25(15):1134\u201348.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"3264_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0202-2","volume":"6","author":"V Neirinckx","year":"2015","unstructured":"Neirinckx V, Agirman G, Coste C, Marquet A, Dion V, Rogister B, et al. Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury. Stem Cell Res Ther. 2015;6(1):1\u201315.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3264_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.transproceed.2006.12.019","volume":"39","author":"S Schrepfer","year":"2007","unstructured":"Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transpl Proc. 2007;39(2):573\u20136.","journal-title":"Transpl Proc"},{"issue":"1","key":"3264_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","volume":"28","author":"G Santamaria","year":"2021","unstructured":"Santamaria G, Brandi E, Vitola P, Grandi F, Ferrara G, Pischiutta F. Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice. Cell Death Differ. 2021;28(1):203\u201318.","journal-title":"Cell Death Differ"},{"issue":"7","key":"3264_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.21037\/atm.2017.03.50","volume":"5","author":"L Beer","year":"2017","unstructured":"Beer L, Mildner M, Ankersmit HJ. Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science. Ann Transl Med. 2017;5(7):170.","journal-title":"Ann Transl Med"},{"key":"3264_CR37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphar.2016.00231","volume":"7","author":"A Marote","year":"2016","unstructured":"Marote A, Teixeira FG, Mendes-Pinheiro B, Salgado AJ. MSCs-derived exosomes: cell-secreted nanovesicles with regenerative potential. Front Pharmacol. 2016;7:231.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3264_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00281-010-0233-9","volume":"33","author":"N Chaput","year":"2011","unstructured":"Chaput N, Th\u00e9ry C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol. 2011;33(5):419\u201340.","journal-title":"Semin Immunopathol"},{"issue":"12","key":"3264_CR39","doi-asserted-by":"publisher","first-page":"8157","DOI":"10.1007\/s12035-019-01663-0","volume":"56","author":"AM Gorabi","year":"2019","unstructured":"Gorabi AM, Kiaie N, Barreto GE, Read MI, Tafti HA, Sahebkar A. The therapeutic potential of mesenchymal stem cell\u2013derived exosomes in treatment of neurodegenerative diseases. Mol Neurobiol. 2019;56(12):8157\u201367.","journal-title":"Mol Neurobiol"},{"key":"3264_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5772\/61186","volume":"4","author":"KJ McKelvey","year":"2015","unstructured":"McKelvey KJ, Powell KL, Ashton AW, Morris JM, McCracken SA. Exosomes: mechanisms of uptake. J Circ Biomark. 2015;4:7.","journal-title":"J Circ Biomark"},{"issue":"5","key":"3264_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/stem.2785","volume":"36","author":"ED Gomes","year":"2018","unstructured":"Gomes ED, Mendes SS, Assun\u00e7\u00e3o-Silva RC, Teixeira FG, Pires AO, Anjo SI. Co-transplantation of adipose tissue-derived stromal cells and olfactory ensheathing cells for spinal cord injury repair. Stem Cells. 2018;36(5):696\u2013708.","journal-title":"Stem Cells"},{"issue":"1","key":"3264_CR42","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/ijms23010456","volume":"23","author":"A Gugliandolo","year":"2022","unstructured":"Gugliandolo A, Mazzon E. Dental mesenchymal stem cell secretome: an intriguing approach for neuroprotection and neuroregeneration. Int J Mol Sci. 2022;23(1):456.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3264_CR43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/cells8020118","volume":"8","author":"H Vila\u00e7a-Faria","year":"2019","unstructured":"Vila\u00e7a-Faria H, Salgado AJ, Teixeira FG. Mesenchymal stem cells-derived exosomes: a new possible therapeutic strategy for Parkinson\u2019s disease? Cells. 2019;8(2):118.","journal-title":"Cells"},{"issue":"14","key":"3264_CR44","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","volume":"77","author":"X-L Fan","year":"2020","unstructured":"Fan X-L, Zhang Y, Li X, Fu Q-L. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci. 2020;77(14):2771\u201394.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"3264_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/cells8050467","volume":"8","author":"CR Harrell","year":"2019","unstructured":"Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells. 2019;8(5):467.","journal-title":"Cells"},{"key":"3264_CR46","doi-asserted-by":"publisher","first-page":"116830","DOI":"10.1016\/j.lfs.2019.116830","volume":"235","author":"SR Mansoor","year":"2019","unstructured":"Mansoor SR, Zabihi E, Ghasemi-Kasman M. The potential use of mesenchymal stem cells for the treatment of multiple sclerosis. Life Sci. 2019;235:116830.","journal-title":"Life Sci"},{"issue":"1","key":"3264_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/neu.2008.0818","volume":"27","author":"H-J Kim","year":"2010","unstructured":"Kim H-J, Lee J-H, Kim S-H. Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis. J Neurotrauma. 2010;27(1):131\u20138.","journal-title":"J Neurotrauma"},{"issue":"1","key":"3264_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0531-4","volume":"8","author":"E Redondo-Castro","year":"2017","unstructured":"Redondo-Castro E, Cunningham C, Miller J, Martuscelli L, Aoulad-Ali S, Rothwell NJ. Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro. Stem Cell Res Therapy. 2017;8(1):1\u201311.","journal-title":"Stem Cell Res Therapy"},{"issue":"3","key":"3264_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt213","volume":"4","author":"Q Li","year":"2013","unstructured":"Li Q, Wang Y, Deng Z. Pre-conditioned mesenchymal stem cells: a better way for cell-based therapy. Stem cell Res Therapy. 2013;4(3):1\u20133.","journal-title":"Stem cell Res Therapy"},{"issue":"1","key":"3264_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-022-00359-z","volume":"27","author":"M Rahbaran","year":"2022","unstructured":"Rahbaran M, Zekiy AO, Bahramali M, Jahangir M, Mardasi M, Sakhaei D, Thangavelu L, Shomali N, Zamani M, Mohammadi A, Rahnama N. Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects. Cell Mol Biol Lett. 2022;27(1):1\u201336.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"3264_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep27791","volume":"6","author":"FG Teixeira","year":"2016","unstructured":"Teixeira FG, Panchalingam KM, Assun\u00e7\u00e3o-Silva R, Serra SC, Mendes-Pinheiro B, Patr\u00edcio P, Jung S, Anjo SI, Manadas B, Pinto L, Sousa N. Modulation of the mesenchymal stem cell secretome using computer-controlled bioreactors: impact on neuronal cell proliferation, survival and differentiation. Sci Rep. 2016;6(1):1\u201314.","journal-title":"Sci Rep"},{"issue":"1","key":"3264_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0124-z","volume":"6","author":"FG Teixeira","year":"2015","unstructured":"Teixeira FG, Panchalingam KM, Anjo SI, Manadas B, Pereira R, Sousa N, Salgado AJ, Behie LA. Do hypoxia\/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome? Stem Cell Res Therapy. 2015;6(1):1\u201314.","journal-title":"Stem Cell Res Therapy"},{"issue":"9","key":"3264_CR53","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3727\/096368913X667709","volume":"23","author":"X Liang","year":"2014","unstructured":"Liang X, Ding Y, Zhang Y, Tse H-F, Lian Q. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2014;23(9):1045\u201359.","journal-title":"Cell Transplant"},{"key":"3264_CR54","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fphar.2020.00499","volume":"11","author":"G Chen","year":"2020","unstructured":"Chen G, Ye Y, Cheng M, Tao Y, Zhang K, Huang Q. Quercetin combined with human umbilical cord Mesenchymal stem cells regulated tumour necrosis factor-\u03b1\/interferon-\u03b3-stimulated peripheral blood mononuclear cells via activation of toll-like receptor 3 Signalling. Front Pharmacol. 2020;11:499.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3264_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1547-8","volume":"11","author":"YM Wan","year":"2020","unstructured":"Wan YM, Qiang LZ, Zhou Q, Liu C, Wang MJ, Wu HX. Mesenchymal stem cells alleviate liver injury induced by chronic-binge ethanol feeding in mice via release of TSG6 and suppression of STAT3 activation. Stem Cell Res Ther. 2020;11(1):1\u201313.","journal-title":"Stem Cell Res Ther"},{"key":"3264_CR56","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fvets.2020.00318","volume":"7","author":"V Caffi","year":"2020","unstructured":"Caffi V, Espinosa G, Gajardo G, Morales N, Dur\u00e1n MC, Uberti B. Pre-conditioning of equine bone marrow-derived mesenchymal stromal cells increases their immunomodulatory capacity. Front Vet Sci. 2020;7:318.","journal-title":"Front Vet Sci"},{"issue":"2","key":"3264_CR57","doi-asserted-by":"publisher","first-page":"634","DOI":"10.5966\/sctm.2016-0071","volume":"6","author":"FG Teixeira","year":"2017","unstructured":"Teixeira FG, Carvalho MM, Panchalingam KM, Rodrigues AJ, Mendes-Pinheiro B, Anjo S, et al. Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson\u2019s disease. Stem Cells Transl Med. 2017;6(2):634\u201346.","journal-title":"Stem Cells Transl Med"},{"key":"3264_CR58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.brainres.2011.10.038","volume":"1431","author":"AL Whone","year":"2012","unstructured":"Whone AL, Kemp K, Sun M, Wilkins A, Scolding NJ. Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor. Brain Res. 2012;1431:86\u201396.","journal-title":"Brain Res"},{"key":"3264_CR59","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1021\/acschemneuro.0c00751","volume":"12","author":"EG Lavigne","year":"2021","unstructured":"Lavigne EG, Buttigieg D, Steinschneider R, Burstein ES. Pimavanserin promotes trophic factor release and protects cultured primary dopaminergic neurons exposed to MPP+ in a GDNF-dependent manner. ACS Chem Neurosci. 2021;12:2088\u201398.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"3264_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03592-1","volume":"7","author":"LF Martins","year":"2017","unstructured":"Martins LF, Costa RO, Pedro JR, Aguiar P, Serra SC, Teixeira FG, et al. Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF. Sci Rep. 2017;7(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"5","key":"3264_CR61","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.neuron.2011.02.052","volume":"70","author":"L Erskine","year":"2011","unstructured":"Erskine L, Reijntjes S, Pratt T, Denti L, Schwarz Q, Vieira JM, et al. VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. Neuron. 2011;70(5):951\u201365.","journal-title":"Neuron"},{"key":"3264_CR62","doi-asserted-by":"crossref","unstructured":"Theis, Verena, and Carsten Theiss. Vascular endothelial growth factor and neurodevelopment. Factors Affecting Neurodevelopment. Academic Press; 2021;237\u201346.","DOI":"10.1016\/B978-0-12-817986-4.00021-3"},{"issue":"5","key":"3264_CR63","doi-asserted-by":"publisher","first-page":"e2774","DOI":"10.1038\/cddis.2017.184","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L, Lin Q, Wang P, Yao L, Leong K, Tan Z, et al. Enhanced neuroprotective efficacy of bone marrow mesenchymal stem cells co-overexpressing BDNF and VEGF in a rat model of cardiac arrest-induced global cerebral ischemia. Cell Death Dis. 2017;8(5):e2774.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3264_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1574888X10666150904114035","volume":"11","author":"MJ Dokic","year":"2016","unstructured":"Dokic MJ, Tomic ZS, Colic JM. Cross-talk between mesenchymal stem\/stromal cells and dendritic cells. Curr Stem Cell Res Ther. 2016;11(1):51\u201365.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"6","key":"3264_CR65","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s13770-014-0072-1","volume":"11","author":"E Chung","year":"2014","unstructured":"Chung E, Son Y. Crosstalk between mesenchymal stem cells and macrophages in tissue repair. Tissue Eng Regener Med. 2014;11(6):431\u20138.","journal-title":"Tissue Eng Regener Med"},{"issue":"2","key":"3264_CR66","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4103\/1673-5374.290881","volume":"16","author":"Y Xu","year":"2021","unstructured":"Xu Y, Jin MZ, Yang ZY, Jin WL. Microglia in neurodegenerative diseases. Neural Regener Res. 2021;16(2):270.","journal-title":"Neural Regener Res"},{"key":"3264_CR67","doi-asserted-by":"publisher","first-page":"146422","DOI":"10.1016\/j.brainres.2019.146422","volume":"1724","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zeng R, Wang Y, Huang W, Hu B, Zhu G. Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6. Brain Res. 2019;1724:146422.","journal-title":"Brain Res"},{"key":"3264_CR68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2019.10.012","volume":"86","author":"A Li","year":"2020","unstructured":"Li A, Zhao J, Fan C, Zhu L, Huang C, Li Q. Delivery of exogenous proteins by mesenchymal stem cells attenuates early memory deficits in a murine model of Alzheimer\u2019s disease. Neurobiol Aging. 2020;86:81\u201391.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3264_CR69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/10245332.2017.1333245","volume":"23","author":"C Liang","year":"2018","unstructured":"Liang C, Jiang E, Yao J, Wang M, Chen S, Zhou Z. Interferon-\u03b3 mediates the immunosuppression of bone marrow mesenchymal stem cells on T-lymphocytes in vitro. Hematology. 2018;23(1):44\u20139.","journal-title":"Hematology"},{"key":"3264_CR70","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3389\/fimmu.2020.01156","volume":"11","author":"M Magatti","year":"2020","unstructured":"Magatti M, Masserdotti A, Bonassi Signoroni P, Vertua E, Stefani FR, Silini AR. B Lymphocytes as targets of the immunomodulatory properties of human amniotic mesenchymal stromal cells. Front Immunol. 2020;11:1156.","journal-title":"Front Immunol"},{"issue":"2","key":"3264_CR71","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12015-014-9583-3","volume":"11","author":"M Gazdic","year":"2015","unstructured":"Gazdic M, Volarevic V, Arsenijevic N, Stojkovic M. Mesenchymal stem cells: a friend or foe in immune-mediated diseases. Stem Cell Rev Rep. 2015;11(2):280\u20137.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"3264_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep26851","volume":"6","author":"JY Lim","year":"2016","unstructured":"Lim JY, Im KI, Lee ES, Kim N, Nam YS, Jeon YW. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis. Sci Rep. 2016;6(1):1\u201313.","journal-title":"Sci Rep"},{"key":"3264_CR73","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci. 2020;41:653\u201364.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"3264_CR74","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nm0405-367","volume":"11","author":"M Gnecchi","year":"2005","unstructured":"Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005;11(4):367\u20138.","journal-title":"Nat Med"},{"key":"3264_CR75","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnmol.2019.00080","volume":"12","author":"H Li","year":"2019","unstructured":"Li H, Yahaya BH, Ng WH, Yusoff NM, Lin J. Conditioned medium of human menstrual blood-derived endometrial stem cells protects against MPP+-induced cytotoxicity in vitro. Front Mol Neurosci. 2019;12:80.","journal-title":"Front Mol Neurosci"},{"key":"3264_CR76","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5736059","author":"A Luarte","year":"2016","unstructured":"Luarte A, B\u00e1tiz LF, Wyneken U, Lafourcade C. Potential therapies by stem cell-derived exosomes in CNS diseases: focusing on the neurogenic niche. Stem Cells Int. 2016. https:\/\/doi.org\/10.1155\/2016\/5736059.","journal-title":"Stem Cells Int"},{"issue":"2","key":"3264_CR77","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12015-014-9576-2","volume":"11","author":"FG Teixeira","year":"2015","unstructured":"Teixeira FG, Carvalho MM, Neves-Carvalho A, Panchalingam KM, Behie LA, Pinto L, et al. Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural\/glial proliferation and differentiation. Stem Cell Rev Rep. 2015;11(2):288\u201397.","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"3264_CR78","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.copbio.2009.08.009","volume":"20","author":"J Wagner","year":"2009","unstructured":"Wagner J, Kean T, Young R, Dennis JE, Caplan AI. Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol. 2009;20(5):531\u20136.","journal-title":"Curr Opin Biotechnol"},{"key":"3264_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/biohorizons\/hzt011","author":"AKL Liu","year":"2013","unstructured":"Liu AKL. Stem cell therapy for Alzheimer\u2019s disease: hype or hope? Biosci Horiz Int J Stud Res. 2013. https:\/\/doi.org\/10.1093\/biohorizons\/hzt011.","journal-title":"Biosci Horiz Int J Stud Res"},{"issue":"12","key":"3264_CR80","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.4103\/1673-5374.262584","volume":"14","author":"R Filadi","year":"2019","unstructured":"Filadi R, Pizzo P. Defective autophagy and Alzheimer\u2019s disease: is calcium the key? Neural Regen Res. 2019;14(12):2081.","journal-title":"Neural Regen Res"},{"issue":"3","key":"3264_CR81","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3233\/JAD-170874","volume":"61","author":"BOA Botchway","year":"2018","unstructured":"Botchway BOA, Moore MK, Akinleye FO, Iyer IC, Fang M. Nutrition: review on the possible treatment for Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2018;61(3):867\u201383.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"3264_CR82","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocn.2018.10.034","volume":"59","author":"MH Ahmad","year":"2019","unstructured":"Ahmad MH, Fatima M, Mondal AC. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease: rational insights for the therapeutic approaches. J Clin Neurosci. 2019;59:6\u201311.","journal-title":"J Clin Neurosci"},{"issue":"5","key":"3264_CR83","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00702-017-1831-7","volume":"125","author":"C Dansokho","year":"2018","unstructured":"Dansokho C, Heneka MT. Neuroinflammatory responses in Alzheimer\u2019s disease. J Neural Transm. 2018;125(5):771\u20139.","journal-title":"J Neural Transm"},{"key":"3264_CR84","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnagi.2016.00160","volume":"8","author":"M Ries","year":"2016","unstructured":"Ries M, Sastre M. Mechanisms of A\u03b2 clearance and degradation by glial cells. Front Aging Neurosci. 2016;8:160.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"3264_CR85","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.neuroscience.2007.02.055","volume":"147","author":"I Glezer","year":"2007","unstructured":"Glezer I, Simard AR, Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience. 2007;147(4):867\u201383.","journal-title":"Neuroscience"},{"issue":"1","key":"3264_CR86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-4159.2010.06736.x","volume":"114","author":"MM Buchanan","year":"2010","unstructured":"Buchanan MM, Hutchinson M, Watkins LR, Yin H. Toll-like receptor 4 in CNS pathologies. J Neurochem. 2010;114(1):13\u201327.","journal-title":"J Neurochem"},{"key":"3264_CR87","doi-asserted-by":"publisher","first-page":"112362","DOI":"10.1016\/j.bbr.2019.112362","volume":"379","author":"S Mehrabadi","year":"2020","unstructured":"Mehrabadi S, Motevaseli E, Sadr SS, Moradbeygi K. Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alternation of toll like receptor (TLR) 2 and TLR4 expression in model of Alzheimer\u2019s disease rats. Behav Brain Res. 2020;379:112362.","journal-title":"Behav Brain Res"},{"issue":"4","key":"3264_CR88","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10787-019-00580-x","volume":"27","author":"D Kaur","year":"2019","unstructured":"Kaur D, Sharma V, Deshmukh R. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer\u2019s disease. Inflammopharmacology. 2019;27(4):663\u201377.","journal-title":"Inflammopharmacology"},{"issue":"18","key":"3264_CR89","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1111\/bph.14586","volume":"176","author":"C Cristiano","year":"2019","unstructured":"Cristiano C, Volpicelli F, Lippiello P, Buono B, Raucci F, Piccolo M. Neutralization of IL-17 rescues amyloid-\u03b2-induced neuroinflammation and memory impairment. Br J Pharmacol. 2019;176(18):3544\u201357.","journal-title":"Br J Pharmacol"},{"key":"3264_CR90","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.nbd.2018.10.009","volume":"121","author":"I Barroeta-Espar","year":"2019","unstructured":"Barroeta-Espar I, Weinstock LD, Perez-Nievas BG, Meltzer AC, Chong MST, Amaral AC. Distinct cytokine profiles in human brains resilient to Alzheimer\u2019s pathology. Neurobiol Dis. 2019;121:327\u201337.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3264_CR91","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10787-019-00613-5","volume":"28","author":"K Yao","year":"2020","unstructured":"Yao K, Bing ZH. Microglial polarization: novel therapeutic mechanism against Alzheimer\u2019s disease. Inflammopharmacology. 2020;28(1):95\u2013110.","journal-title":"Inflammopharmacology"},{"key":"3264_CR92","doi-asserted-by":"publisher","first-page":"564077","DOI":"10.3389\/fimmu.2020.564077","volume":"11","author":"UM Kinuthia","year":"2020","unstructured":"Kinuthia UM, Wolf A, Langmann T. Microglia and inflammatory responses in diabetic retinopathy. Front Immunol. 2020;11:564077.","journal-title":"Front Immunol"},{"issue":"9","key":"3264_CR93","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/stem.1174","volume":"30","author":"D Giunti","year":"2012","unstructured":"Giunti D, Parodi B, Usai C, Vergani L, Casazza S, Bruzzone S, et al. Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem cells. 2012;30(9):2044\u201353.","journal-title":"Stem cells"},{"issue":"2","key":"3264_CR94","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1096\/fj.09-141754","volume":"24","author":"P Chakrabarty","year":"2010","unstructured":"Chakrabarty P, Jansen-West K, Beccard A, Ceballos-Diaz C, Levites Y, Verbeeck C. Massive gliosis induced by interleukin-6 suppresses A\u03b2 deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J. 2010;24(2):548\u201359.","journal-title":"FASEB J"},{"issue":"1","key":"3264_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-016-0054-4","volume":"5","author":"C Zheng","year":"2016","unstructured":"Zheng C, Zhou XW, Wang JZ. The dual roles of cytokines in Alzheimer\u2019s disease: update on interleukins, TNF-\u03b1, TGF-\u03b2 and IFN-\u03b3. Transl Neurodegener. 2016;5(1):1\u201315.","journal-title":"Transl Neurodegener"},{"issue":"2","key":"3264_CR96","doi-asserted-by":"publisher","first-page":"e0116549","DOI":"10.1371\/journal.pone.0116549","volume":"10","author":"JH Chen","year":"2015","unstructured":"Chen JH, Ke KF, Lu JH, Qiu YH, Peng YP. Protection of TGF-\u03b21 against neuroinflammation and neurodegeneration in A\u03b21\u201342-induced Alzheimer\u2019s disease model rats. PLoS One. 2015;10(2):e0116549.","journal-title":"PLoS One"},{"issue":"1\u20132","key":"3264_CR97","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.brainresrev.2011.01.002","volume":"67","author":"A Spooren","year":"2011","unstructured":"Spooren A, Kolmus K, Laureys G, Clinckers R, Keyser J, Haegeman G. Interleukin-6, a mental cytokine. Brain Res Rev. 2011;67(1\u20132):157\u201383.","journal-title":"Brain Res Rev"},{"key":"3264_CR98","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbi.2019.08.005","volume":"82","author":"A Escrig","year":"2019","unstructured":"Escrig A, Canal C, Sanchis P, Fern\u00e1ndez-Gayol O, Montilla A, Comes G. IL-6 trans-signaling in the brain influences the behavioral and physio-pathological phenotype of the Tg2576 and 3xTgAD mouse models of Alzheimer\u2019s disease. Brain Behav Immun. 2019;82:145\u201359.","journal-title":"Brain Behav Immun"},{"key":"3264_CR99","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.expneurol.2018.09.006","volume":"311","author":"M He","year":"2019","unstructured":"He M, Shi X, Yang M, Yang T, Li T, Chen J. Mesenchymal stem cells-derived IL-6 activates AMPK\/mTOR signaling to inhibit the proliferation of reactive astrocytes induced by hypoxic-ischemic brain damage. Exp Neurol. 2019;311:15\u201332.","journal-title":"Exp Neurol"},{"issue":"7","key":"3264_CR100","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/stem.1125","volume":"30","author":"JK Lee","year":"2012","unstructured":"Lee JK, Schuchman EH, Jin HK, Bae J. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid \u03b2 ameliorates Alzheimer\u2019s disease in mice by recruiting bone marrow-induced microglia immune responses. Stem Cells. 2012;30(7):1544\u201355.","journal-title":"Stem Cells"},{"issue":"9","key":"3264_CR101","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.4103\/1673-5374.255975","volume":"14","author":"RH Tang","year":"2019","unstructured":"Tang RH, Qi RQ, Liu HY. Interleukin-4 affects microglial autophagic flux. Neural Regen Res. 2019;14(9):1594\u2013602.","journal-title":"Neural Regen Res"},{"key":"3264_CR102","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.biopha.2018.02.043","volume":"101","author":"MG Feng","year":"2018","unstructured":"Feng MG, Liu CF, Chen L, Feng WB, Liu M, Hai H. MiR-21 attenuates apoptosis-triggered by amyloid-\u03b2 via modulating PDCD4\/PI3K\/AKT\/GSK-3\u03b2 pathway in SH-SY5Y cells. Biomed Pharmacother. 2018;101:1003\u20137.","journal-title":"Biomed Pharmacother"},{"key":"3264_CR103","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neulet.2014.12.033","volume":"587","author":"T Kanamaru","year":"2015","unstructured":"Kanamaru T, Kamimura N, Yokota T, Iuchi K, Nishimaki K, Takami S. Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer\u2019s disease. Neurosci Lett. 2015;587:126\u201331.","journal-title":"Neurosci Lett"},{"key":"3264_CR104","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet Lond Engl. 2018;391:1622\u201336.","journal-title":"Lancet Lond Engl"},{"issue":"1\u20132","key":"3264_CR105","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jns.2014.12.035","volume":"349","author":"P Iwanowski","year":"2015","unstructured":"Iwanowski P, Losy J. Immunological differences between classical phenothypes of multiple sclerosis. J Neurol Sci. 2015;349(1\u20132):10\u20134.","journal-title":"J Neurol Sci"},{"issue":"10076","key":"3264_CR106","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(16)31320-4","volume":"389","author":"D Ontaneda","year":"2017","unstructured":"Ontaneda D, Thompson AJ, Fox RJ, Cohen JA. Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function. Lancet. 2017;389(10076):1357\u201366.","journal-title":"Lancet"},{"issue":"4","key":"3264_CR107","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple sclerosis: mechanisms and immunotherapy. Neuron. 2018;97(4):742\u201368.","journal-title":"Neuron"},{"key":"3264_CR108","doi-asserted-by":"crossref","unstructured":"Wagner CA, Roqu\u00e9 PJ, Goverman JM. Pathogenic T cell cytokines in multiple sclerosis. J Exp Med. 2020;217(1).","DOI":"10.1084\/jem.20190460"},{"key":"3264_CR109","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3727\/096368914X685005","volume":"23","author":"J-F Li","year":"2014","unstructured":"Li J-F, Zhang D-J, Geng T, Chen L, Huang H, Yin H-L, et al. The potential of human umbilical cord-derived mesenchymal stem cells as a novel cellular therapy for multiple sclerosis. Cell Transplant. 2014;23:113\u201322.","journal-title":"Cell Transplant"},{"issue":"12","key":"3264_CR110","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/jcm8122102","volume":"8","author":"E Iacobaeus","year":"2019","unstructured":"Iacobaeus E, Kadri N, Lefsihane K, Boberg E, Gavin C, T\u00f6rnqvist Andr\u00e9n A, et al. Short and long term clinical and immunologic follow up after bone marrow mesenchymal stromal cell therapy in progressive multiple sclerosis\u2014a phase i study. J Clin Medi. 2019;8(12):2102.","journal-title":"J Clin Medi"},{"issue":"9","key":"3264_CR111","doi-asserted-by":"publisher","first-page":"e00362","DOI":"10.1002\/brb3.362","volume":"5","author":"N Garg","year":"2015","unstructured":"Garg N, Smith TW. An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav. 2015;5(9):e00362.","journal-title":"Brain Behav."},{"issue":"9","key":"3264_CR112","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.exphem.2012.05.006","volume":"40","author":"X Qu","year":"2012","unstructured":"Qu X, Liu X, Cheng K, Yang R, Zhao RCH. Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion. Exp Hematol. 2012;40(9):761\u201370.","journal-title":"Exp Hematol"},{"issue":"1","key":"3264_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0499-0","volume":"8","author":"W-X Gao","year":"2017","unstructured":"Gao W-X, Sun Y-Q, Shi J, Li C-L, Fang S-B, Wang D, et al. Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells. Stem Cell Res Ther. 2017;8(1):1\u201316.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3264_CR114","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/biomedicines3010138","volume":"3","author":"J H\u00fcbel","year":"2015","unstructured":"H\u00fcbel J, Hieronymus T. HGF\/Met-signaling contributes to immune regulation by modulating tolerogenic and motogenic properties of dendritic cells. Biomedicines. 2015;3(1):138\u201348.","journal-title":"Biomedicines"},{"issue":"6","key":"3264_CR115","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nn.3109","volume":"15","author":"L Bai","year":"2012","unstructured":"Bai L, Lennon DP, Caplan AI, DeChant A, Hecker J, Kranso J, et al. Hepatocyte growth factor mediates mesenchymal stem cell\u2013induced recovery in multiple sclerosis models. Nat Neurosci. 2012;15(6):862\u201370.","journal-title":"Nat Neurosci"},{"key":"3264_CR116","doi-asserted-by":"publisher","first-page":"104456","DOI":"10.1016\/j.phrs.2019.104456","volume":"149","author":"D Maseda","year":"2019","unstructured":"Maseda D, Ricciotti E, Crofford LJ. Prostaglandin regulation of T cell biology. Pharmacol Res. 2019;149:104456.","journal-title":"Pharmacol Res"},{"issue":"3","key":"3264_CR117","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20082293","volume":"206","author":"K Boniface","year":"2009","unstructured":"Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK, et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2\/EP4 receptor signaling. J Exp Med. 2009;206(3):535\u201348.","journal-title":"J Exp Med"},{"issue":"2","key":"3264_CR118","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s12035-018-1137-2","volume":"56","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Dong H, Seeburg DP, Wojtkiewicz GR, Waterman P, Pulli B, et al. Multimodal molecular imaging demonstrates myeloperoxidase regulation of matrix metalloproteinase activity in neuroinflammation. Mol Neurobiol. 2019;56(2):954\u201362.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"3264_CR119","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1159\/000485533","volume":"44","author":"B Chelluboina","year":"2017","unstructured":"Chelluboina B, Nalamolu KR, Mendez GG, Klopfenstein JD, Pinson DM, Wang DZ, et al. Mesenchymal stem cell treatment prevents post-stroke dysregulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Cell Physiol Biochem. 2017;44(4):1360\u20139.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"3264_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-18144-w","volume":"7","author":"AG Kay","year":"2017","unstructured":"Kay AG, Long G, Tyler G, Stefan A, Broadfoot SJ, Piccinini AM, et al. Mesenchymal stem cell-conditioned medium reduces disease severity and immune responses in inflammatory arthritis. Sci Rep. 2017;7(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"2","key":"3264_CR121","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jcp.22344","volume":"226","author":"TP Lozito","year":"2011","unstructured":"Lozito TP, Tuan RS. Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol. 2011;226(2):385\u201396.","journal-title":"J Cell Physiol"},{"issue":"5","key":"3264_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2565-2","volume":"11","author":"B Hou","year":"2020","unstructured":"Hou B, Zhang Y, Liang P, He Y, Peng B, Liu W, et al. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype. Cell Death Dis. 2020;11(5):1\u201316.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3264_CR123","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0394632017722332","volume":"30","author":"T Soundara Rajan","year":"2017","unstructured":"Soundara Rajan T, Giacoppo S, Diomede F, Bramanti P, Trubiani O, Mazzon E. Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis. Int J Immunopathol Pharmacol. 2017;30(3):238\u201352.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"3264_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep14488","volume":"5","author":"P Gurung","year":"2015","unstructured":"Gurung P, Li B, Malireddi RKS, Lamkanfi M, Geiger TL, Kanneganti T-D. Chronic TLR stimulation controls NLRP3 inflammasome activation through IL-10 mediated regulation of NLRP3 expression and caspase-8 activation. Sci Rep. 2015;5(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"1","key":"3264_CR125","doi-asserted-by":"publisher","first-page":"FNL38","DOI":"10.2217\/fnl-2019-0018","volume":"15","author":"Z Karmand","year":"2020","unstructured":"Karmand Z, Hartung HP, Neuhaus O. Interferon beta-1a induces expression of brain-derived neurotrophic factor in human T lymphocytes in vitro and not in vivo. Future Neurol. 2020;15(1):FNL38.","journal-title":"Future Neurol"},{"key":"3264_CR126","doi-asserted-by":"publisher","first-page":"102143","DOI":"10.1016\/j.msard.2020.102143","volume":"43","author":"E Banitalebi","year":"2020","unstructured":"Banitalebi E, Ghahfarrokhi MM, Negaresh R, Kazemi A, Faramarzi M, Motl RW. Exercise improves neurotrophins in multiple sclerosis independent of disability status. Mult Scler Related Disord. 2020;43:102143.","journal-title":"Mult Scler Related Disord"},{"key":"3264_CR127","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fneur.2018.00357","volume":"9","author":"AS Shalash","year":"2018","unstructured":"Shalash AS, Hamid E, Elrassas HH, Bedair AS, Abushouk AI, Khamis M. Non-motor symptoms as predictors of quality of life in Egyptian patients with Parkinson\u2019s disease: a cross-sectional study using a culturally adapted 39-item Parkinson\u2019s disease questionnaire. Front Neurol. 2018;9:357.","journal-title":"Front Neurol"},{"issue":"2","key":"3264_CR128","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.27907","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne S, Kondru N, Jin H, Anantharam V, Huang X, Kanthasamy A. \u03b1-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson\u2019s disease patients. Mov Disord. 2020;35(2):268\u201378.","journal-title":"Mov Disord"},{"key":"3264_CR129","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S. The clinical symptoms of Parkinson\u2019s disease. J Neurochem. 2016;139:318\u201324.","journal-title":"J Neurochem"},{"issue":"6","key":"3264_CR130","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/14737175.2016.1179112","volume":"16","author":"T Shen","year":"2016","unstructured":"Shen T, Pu J, Si X, Ye R, Zhang B. An update on potential therapeutic strategies for Parkinson\u2019s disease based on pathogenic mechanisms. Expert Rev Neurother. 2016;16(6):711\u201322.","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"3264_CR131","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med. 2008;14(5):501\u20133.","journal-title":"Nat Med"},{"issue":"2","key":"3264_CR132","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","volume":"155","author":"NK Venkataramana","year":"2010","unstructured":"Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson\u2019s disease. Transl Res. 2010;155(2):62\u201370.","journal-title":"Transl Res"},{"issue":"7","key":"3264_CR133","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/dneu.22077","volume":"73","author":"F Sakane","year":"2013","unstructured":"Sakane F, Miyamoto Y. N-cadherin regulates the proliferation and differentiation of ventral midbrain dopaminergic progenitors. Dev Neurobiol. 2013;73(7):518\u201329.","journal-title":"Dev Neurobiol"},{"issue":"2","key":"3264_CR134","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/cells9020315","volume":"9","author":"FG Teixeira","year":"2020","unstructured":"Teixeira FG, Vila\u00e7a-Faria H, Domingues AV, Campos J, Salgado AJ. Preclinical comparison of stem cells secretome and levodopa application in a 6-hydroxydopamine rat model of Parkinson\u2019s disease. Cells. 2020;9(2):315.","journal-title":"Cells"},{"issue":"9","key":"3264_CR135","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.5966\/sctm.2015-0023","volume":"4","author":"S Cerri","year":"2015","unstructured":"Cerri S, Greco R, Levandis G, Ghezzi C, Mangione AS, Fuzzati-Armentero MT. Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson\u2019s disease, focusing on cell distribution and neuroprotective and behavioral effects. Stem Cells Transl Med. 2015;4(9):1073\u201385.","journal-title":"Stem Cells Transl Med"},{"issue":"26","key":"3264_CR136","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1523\/JNEUROSCI.4601-04.2005","volume":"25","author":"ZC Baquet","year":"2005","unstructured":"Baquet ZC, Bickford PC, Jones KR. Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci. 2005;25(26):6251\u20139.","journal-title":"J Neurosci"},{"issue":"2","key":"3264_CR137","first-page":"32-39","volume":"697","author":"N zhang","year":"2012","unstructured":"Zhang, N.; Kang, T.; Xia, Y.; Wen, Q.; Zhang, X.; Li, H.; Hu, Y.; Hao, H.; Zhao, D.; Sun, D.; et al. Effects of salvianolic acid B on survival, self-renewal and neuronal differentiation of bone marrow derived neural stem cells. Eur. J. Pharmacol. 2012, 697, 32\u201339","journal-title":"Eur. J. Pharmacol."},{"key":"3264_CR138","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fncel.2020.00082","volume":"14","author":"T Yang","year":"2020","unstructured":"Yang T, Nie Z, Shu H, Kuang Y, Chen X, Cheng J. The role of BDNF on neural plasticity in depression. Front Cell Neurosci. 2020;14:82.","journal-title":"Front Cell Neurosci"},{"key":"3264_CR139","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fnagi.2017.00358","volume":"9","author":"L Hou","year":"2017","unstructured":"Hou L, Chen W, Liu X, Qiao D, Zhou FM. Exercise-induced neuroprotection of the nigrostriatal dopamine system in Parkinson\u2019s disease. Front Aging Neurosci. 2017;9:358.","journal-title":"Front Aging Neurosci"},{"key":"3264_CR140","doi-asserted-by":"publisher","first-page":"096368972090851","DOI":"10.1177\/0963689720908512","volume":"29","author":"S Sun","year":"2020","unstructured":"Sun S, Zhang Q, Li M, Gao P, Huang K, Beejadhursing R. GDNF promotes survival and therapeutic efficacy of human adipose-derived mesenchymal stem cells in a mouse model of Parkinson\u2019s disease. Cell Transplant. 2020;29:0963689720908512.","journal-title":"Cell Transplant"},{"issue":"10","key":"3264_CR141","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3109\/00207454.2013.795149","volume":"123","author":"JP Cao","year":"2013","unstructured":"Cao JP, Niu HY, Wang HJ, Huang XG, Gao DS. NF-\u03baB p65\/p52 plays a role in GDNF up-regulating Bcl-2 and Bcl-w expression in 6-OHDA-induced apoptosis of MN9D cell. Int J Neurosci. 2013;123(10):705\u201310.","journal-title":"Int J Neurosci"},{"issue":"6","key":"3264_CR142","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0028-3908(99)00030-1","volume":"38","author":"CC Chao","year":"1999","unstructured":"Chao CC, Lee EHY. Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of antioxidation. Neuropharmacology. 1999;38(6):913\u20136.","journal-title":"Neuropharmacology"},{"issue":"9","key":"3264_CR143","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8(9):1254.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3264_CR144","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1006\/exnr.1995.1082","volume":"136","author":"Y Akaneya","year":"1995","unstructured":"Akaneya Y, Takahashi M, Hatanaka H. Interleukin-1\u03b2 enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp Neurol. 1995;136(1):44\u201352.","journal-title":"Exp Neurol"},{"issue":"1","key":"3264_CR145","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1471-4159.2002.01131.x","volume":"83","author":"LM Bolin","year":"2002","unstructured":"Bolin LM, Strycharska-Orczyk I, Murray R, Langston JW, Monte D. Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. J Neurochem. 2002;83(1):167\u201375.","journal-title":"J Neurochem"},{"issue":"3","key":"3264_CR146","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms21031170","volume":"21","author":"E Palasz","year":"2020","unstructured":"Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G. BDNF as a promising therapeutic agent in Parkinson\u2019s disease. Int J Mol Sci. 2020;21(3):1170.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3264_CR147","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1046\/j.1471-4159.1995.65031016.x","volume":"65","author":"D Casper","year":"1995","unstructured":"Casper D, Blum M. Epidermal growth factor and basic fibroblast growth factor protect dopaminergic neurons from glutamate toxicity in culture. J Neurochem. 1995;65(3):1016\u201326.","journal-title":"J Neurochem"},{"issue":"2","key":"3264_CR148","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.expneurol.2007.05.012","volume":"206","author":"T Yasuda","year":"2007","unstructured":"Yasuda T, Fukuda-Tani M, Nihira T, Wada K, Hattori N, Mizuno Y. Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson\u2019s disease. Exp Neurol. 2007;206(2):308\u201317.","journal-title":"Exp Neurol"},{"issue":"6","key":"3264_CR149","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/cbdd.13681","volume":"95","author":"X Meng","year":"2020","unstructured":"Meng X, Huang A, Khan A, Zhang L, Sun X, Song H. Vascular endothelial growth factor-loaded poly-lactic-co-glycolic acid nanoparticles with controlled release protect the dopaminergic neurons in Parkinson\u2019s rats. Chem Biol Drug Des. 2020;95(6):631\u20139.","journal-title":"Chem Biol Drug Des"},{"issue":"8","key":"3264_CR150","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.3390\/ijms11082875","volume":"11","author":"T Falk","year":"2010","unstructured":"Falk T, Gonzalez RT, Sherman SJ. The Yin and Yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson\u2019s disease. Int J Mol Sci. 2010;11(8):2875\u2013900.","journal-title":"Int J Mol Sci"},{"key":"3264_CR151","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fbioe.2019.00294","volume":"7","author":"B Mendes-Pinheiro","year":"2019","unstructured":"Mendes-Pinheiro B, Anjo SI, Manadas B, Silva JD, Marote A, Behie LA, et al. Bone marrow mesenchymal stem cells\u2019 secretome exerts neuroprotective efects in a Parkinson\u2019s disease rat model. Front Bioeng Biotechnol. 2019;7:294.","journal-title":"Front Bioeng Biotechnol"},{"issue":"8","key":"3264_CR152","doi-asserted-by":"publisher","first-page":"798","DOI":"10.4103\/1673-5374.131596","volume":"9","author":"Y Gong","year":"2014","unstructured":"Gong Y, Yan Y, Ma T, Gong K, Ao Q, Zhang X. Adipose-derived mesenchymal stem cell transplantation promotes adult neurogenesis in the brains of Alzheimer\u2019s disease mice. Neural Regener Res. 2014;9(8):798\u2013805","journal-title":"Neural Regener Res."},{"issue":"20","key":"3264_CR153","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1089\/scd.2014.0487","volume":"24","author":"D Kim","year":"2015","unstructured":"Kim D, Lee D, Chang E, et al. GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer's disease model. Stem Cells Develop. 2015;24(20):2378\u20132390","journal-title":"Stem Cells Develop."},{"key":"3264_CR154","doi-asserted-by":"crossref","unstructured":"Xie ZH, Liu Z, Zhang XR, Yang H, Wei LF, Wang Y, Xu SL, Sun L, Lai C, Bi JZ, Wang XY. Wharton's Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-\u03b2 deposition in an APP\/PS1 transgenic mouse model. Clin Exp Med. 2016, 16(1),89\u201398. https:\/\/doi.org\/10.1007\/s10238-015-0375-0","DOI":"10.1007\/s10238-015-0375-0"},{"key":"3264_CR155","doi-asserted-by":"crossref","unstructured":"Nakano, M., Kubota, K., Kobayashi, E. et al. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer\u2019s disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep 10:10772","DOI":"10.1038\/s41598-020-67460-1"},{"issue":"8","key":"3264_CR156","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s12272-016-0799-4","volume":"39","author":"SE Park","year":"2016","unstructured":"Park SE, Lee J, Chang EH, Kim JH, Sung JH, Na DL, Chang JW. Activin A secreted by human mesenchymal stem cells induces neuronal development and neurite outgrowth in an in vitro model of Alzheimer's disease: neurogenesis induced by MSCs via activin A. Arch Pharm Res. 2016;39(8):1171\u20139","journal-title":"Arch Pharm Res."},{"key":"3264_CR157","doi-asserted-by":"publisher","first-page":"39340","DOI":"10.1038\/srep39340","volume":"7","author":"NK Lee","year":"2017","unstructured":"Lee NK, Park SE, Kwon SJ, Shim S, Byeon Y, Kim JH, Na DL, Chang JW. Agouti Related Peptide Secreted Via Human Mesenchymal Stem Cells Upregulates Proteasome Activity in an Alzheimer's Disease Model. Sci Rep. 2017;7:39340","journal-title":"Sci Rep."},{"issue":"8","key":"3264_CR158","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s11064-017-2226-8","volume":"42","author":"XY Zheng","year":"2017","unstructured":"Zheng XY, Wan QQ, Zheng CY, Zhou HL, Dong XY, Deng QS, Yao H, Fu Q, Gao M, Yan ZJ, Wang SS, You Y, Lv J, Wang XY, Chen KE, Zhang MY, Xu RX. Amniotic Mesenchymal Stem Cells Decrease A\u03b2 Deposition and Improve Memory in APP\/PS1 Transgenic Mice. Neurochem Res. 2017;42(8):2191\u20132207","journal-title":"Neurochem Res."},{"issue":"4","key":"3264_CR159","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/nan.12319","volume":"43","author":"Y Naaldijk","year":"2017","unstructured":"Naaldijk Y, J\u00e4ger C, Fabian C, Leovsky C, Bl\u00fcher A, Rudolph L, Hinze A, Stolzing A. Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP\/PS1 Alzheimer mice. Neuropathol Appl Neurobiol. 2017;43(4):299\u2013314","journal-title":"Neuropathol Appl Neurobiol."},{"issue":"1","key":"3264_CR160","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41598-017-18542-0","volume":"8","author":"DH Kim","year":"2018","unstructured":"Kim DH, Lim H, Lee D, Choi SJ, Oh W, Yang YS, Oh JS, Hwang HH, Jeon HB. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model. Sci Rep. 2018;8(1):354","journal-title":"Sci Rep."},{"key":"3264_CR161","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnmol.2018.00140","volume":"11","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Chen X, Wu Y, Wang Y, Li Y, Xiang C. Transplantation of Human Menstrual Blood-Derived Mesenchymal Stem Cells Alleviates Alzheimer's Disease-Like Pathology in APP\/PS1 Transgenic Mice. Front Mol Neurosci. 2018;11:140","journal-title":"Front Mol Neurosci."},{"issue":"9","key":"3264_CR162","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1177\/0004867420917467","volume":"54","author":"BN Park","year":"2020","unstructured":"Park BN, Kim JH, Lim TS, Park SH, Kim TG, Yoon BS, Son KS, Yoon JK, An YS. Therapeutic effect of mesenchymal stem cells in an animal model of Alzheimer\u2019s disease evaluated by \u03b2-amyloid positron emission tomography imaging. Aust N Z J Psychiatry. 2020;54(9):883\u201391.","journal-title":"Aust N Z J Psychiatry."},{"key":"3264_CR163","doi-asserted-by":"publisher","first-page":"8878412","DOI":"10.1155\/2020\/8878412","volume":"2020","author":"H Lim","year":"2020","unstructured":"Lim H, Lee D, Choi W, Choi S, Oh W, Kim D. Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces aberrant tau phosphorylation in an Alzheimer disease model. Stem Cells Int. 2020;2020:8878412.","journal-title":"Stem Cells Int."},{"key":"3264_CR164","doi-asserted-by":"publisher","first-page":"10772","DOI":"10.1038\/s41598-020-67460-1","volume":"10","author":"M Nakano","year":"2020","unstructured":"Nakano M, Kubota K, Kobayashi E, et al. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer\u2019s disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep. 2020;10:10772.","journal-title":"Sci Rep"},{"issue":"1","key":"3264_CR165","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","volume":"28","author":"G Santamaria","year":"2021","unstructured":"Santamaria G, Brandi E, Vitola P, Grandi F, Ferrara G, Pischiutta F, Vegliante G, Zanier ER, Re F, Uccelli A, Forloni G, de Rosbo NK, Balducci C. Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice. Cell Death Differ. 2021;28(1):203\u201318.","journal-title":"Cell Death Differ."},{"key":"3264_CR166","doi-asserted-by":"crossref","unstructured":"Park, Kim H, Kwon S, et al. Exposure of mesenchymal stem cells to an Alzheimer\u2019s disease environment enhances 10 Stem Cells Internationaltherapeutic effects. Stem Cells Int. 2021;2021:6660186.","DOI":"10.1155\/2021\/6660186"},{"key":"3264_CR167","doi-asserted-by":"crossref","unstructured":"Kurte M, Bravo-Alegria J, Torres A, Carrasco V, Ibanez C, Vega-Letter AM, Fernandez-O\u2019Ryan C, Irarrazabal CE, Figueroa FE, Fuentealba RA, et al. Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis. Stem Cells Int. 2015;2015:140170.","DOI":"10.1155\/2015\/140170"},{"key":"3264_CR168","doi-asserted-by":"crossref","unstructured":"Glenn JD, Smith MD, Kirby LA, Baxi EG, Whartenby KA. Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination. PLoS One. 2015;10(9).","DOI":"10.1371\/journal.pone.0139008"},{"key":"3264_CR169","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.aanat.2014.12.002","volume":"198","author":"G El-Akabawy","year":"2015","unstructured":"El-Akabawy G, Rashed LA. Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination. Ann Anat. 2015;198:11\u201320. https:\/\/doi.org\/10.1016\/j.aanat.2014.12.002.","journal-title":"Ann Anat."},{"key":"3264_CR170","doi-asserted-by":"publisher","first-page":"2389753","DOI":"10.1155\/2017\/2389753","volume":"2017","author":"P Anderson","year":"2017","unstructured":"Anderson P, Gonzalez-Rey E, O\u2019Valle F, Martin F, Oliver FJ, Delgado M. Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function. Stem Cells Int. 2017;2017:2389753.","journal-title":"Stem Cells Int."},{"key":"3264_CR171","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.21936","author":"MM Mahfouz","year":"2017","unstructured":"Mahfouz MM, Abdelsalam RM, Masoud MA, Mansour HA, Ahmed-Farid OA, Kenawy SA. The neuroprotective effect of mesenchymal stem cells on an experimentally induced model for multiple sclerosis in mice. J Biochem Mol Toxicol. 2017. https:\/\/doi.org\/10.1002\/jbt.21936.","journal-title":"J Biochem Mol Toxicol."},{"key":"3264_CR172","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1038\/s41598-017-06251-7","volume":"7","author":"A Cedola","year":"2017","unstructured":"Cedola A, Bravin A, Bukreeva I, et al. X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model. Sci Rep. 2017;7:5890. https:\/\/doi.org\/10.1038\/s41598-017-06251-7.","journal-title":"Sci Rep."},{"key":"3264_CR173","doi-asserted-by":"publisher","first-page":"312","DOI":"10.29252\/ibj.22.5.312","volume":"22","author":"M Marzban","year":"2018","unstructured":"Marzban M, Mousavizadeh K, Bakhshayesh M, Vousooghi N, Vakilzadeh G, Torkaman-Boutorabi A. Effect of Multiple Intraperitoneal Injections of Human Bone Marrow Mesenchymal Stem Cells on Cuprizone Model of Multiple Sclerosis. Iran Biomed J. 2018;22:312\u201321.","journal-title":"Iran. Biomed. J."},{"key":"3264_CR174","doi-asserted-by":"crossref","unstructured":"Kurte M, Luz-Crawford P, Vega-Letter AM, Contreras RA, Tejedor G, Elizondo-Vega R, Martinez-Viola L, Fernandez-O\u2019Ryan C, Figueroa FE, Jorgensen C, et al. IL17\/IL17RA as a novel signaling axis driving mesenchymal stem cell therapeutic function in experimental autoimmune encephalomyelitis. Front. Immunol. 2018;9:802.","DOI":"10.3389\/fimmu.2018.00802"},{"issue":"8","key":"3264_CR175","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/glia.23624","volume":"67","author":"FJ Rivera","year":"2019","unstructured":"Rivera FJ, de la Fuente AG, Zhao C, Silva ME, Gonzalez GA, Wodnar R, Feichtner M, Lange S, Errea O, Priglinger E, O\u2019Sullivan A, Romanelli P, Jadasz JJ, Brachtl G, Greil R, Tempfer H, Traweger A, B\u00e1tiz LF, K\u00fcry P, Couillard-Despres S, Franklin RJM, Aigner L. Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination. Glia. 2019;67(8):1510\u201325. https:\/\/doi.org\/10.1002\/glia.23624.","journal-title":"Glia."},{"key":"3264_CR176","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.npep.2019.04.001","volume":"75","author":"S Barati","year":"2019","unstructured":"Barati S, Kashani IR, Tahmasebi F, Mehrabi S, Joghataei MT. Effect of mesenchymal stem cells on glial cells population in cuprizone induced demyelination model. Neuropeptides. 2019;75:75\u201384.","journal-title":"Neuropeptides"},{"issue":"8","key":"3264_CR177","doi-asserted-by":"publisher","first-page":"13952","DOI":"10.1002\/jcb.28670","volume":"120","author":"S Barati","year":"2019","unstructured":"Barati S, Ragerdi Kashani I, Moradi F, Tahmasebi F, Mehrabi S, Barati M, Joghataei MT. Mesenchymal stem cell mediated effects on microglial phenotype in cuprizone-induced demyelination model. J Cell Biochem. 2019;120(8):13952\u201364. https:\/\/doi.org\/10.1002\/jcb.28670.","journal-title":"J Cell Biochem."},{"key":"3264_CR178","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.imlet.2020.05.005","volume":"225","author":"Y Xin","year":"2020","unstructured":"Xin Y, Gao J, Hu R, Li H, Li Q, Han F, He Z, Lai L, Su M. Changes of immune parameters of T lymphocytes and macrophages in EAE mice after BM-MSCs transplantation. Immunol Lett. 2020;225:66\u201373.","journal-title":"Immunol. Lett."},{"issue":"9","key":"3264_CR179","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1007\/s12035-020-01998-z","volume":"57","author":"Y Liu","year":"2020","unstructured":"Liu Y, Ma Y, Du B, Wang Y, Yang GY, Bi X. Mesenchymal Stem Cells Attenuated Blood-Brain Barrier Disruption via Downregulation of Aquaporin-4 Expression in EAE Mice. Mol Neurobiol. 2020;57(9):3891\u2013901. https:\/\/doi.org\/10.1007\/s12035-020-01998-z.","journal-title":"Mol Neurobiol."},{"issue":"8","key":"3264_CR180","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/tvst.9.8.16","volume":"9","author":"OW Gramlich","year":"2020","unstructured":"Gramlich OW, Brown AJ, Godwin CR, Chimenti MS, Boland LK, Ankrum JA, Kardon RH. Systemic Mesenchymal Stem Cell Treatment Mitigates Structural and Functional Retinal Ganglion Cell Degeneration in a Mouse Model of Multiple Sclerosis. Transl Vis Sci Technol. 2020;9(8):16. https:\/\/doi.org\/10.1167\/tvst.9.8.16.","journal-title":"Transl Vis Sci Technol."},{"issue":"1","key":"3264_CR181","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1471-4159.2008.05589.x","volume":"107","author":"HJ Park","year":"2008","unstructured":"Park HJ, Lee PH, Bang OY, Lee G, Ahn YH. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson\u2019s disease. J Neurochem. 2008;107(1):141\u201351. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05589.x.","journal-title":"J Neurochem."},{"issue":"7","key":"3264_CR182","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.neuint.2008.02.003","volume":"52","author":"G Bouchez","year":"2008","unstructured":"Bouchez G, Senseb\u00e9 L, Vourc\u2019h P, Garreau L, Bodard S, Rico A, Guilloteau D, Charbord P, Besnard JC, Chalon S. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson\u2019s disease. Neurochem Int. 2008;52(7):1332\u201342. https:\/\/doi.org\/10.1016\/j.neuint.2008.02.003.","journal-title":"Neurochem Int."},{"issue":"1","key":"3264_CR183","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.09.003","volume":"216","author":"YX Chao","year":"2009","unstructured":"Chao YX, He BP, Tay SSW. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinfammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson\u2019s disease. J Neuroimmunol. 2009;216(1):39\u201350.","journal-title":"J Neuroimmunol."},{"key":"3264_CR184","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainres.2009.11.041","volume":"1311","author":"L Cova","year":"2010","unstructured":"Cova L, Armentero MT, Zennaro E, Calzarossa C, Bossolasco P, Busca G, Lambertenghi Deliliers G, Polli E, Nappi G, Silani V, Blandini F. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson\u2019s disease. Brain Res. 2010;1311:12\u201327. https:\/\/doi.org\/10.1016\/j.brainres.2009.11.041.","journal-title":"Brain Res."},{"issue":"4","key":"3264_CR185","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1582-4934.2010.01068.x","volume":"15","author":"EF Wolff","year":"2011","unstructured":"Wolff EF, Gao XB, Yao KV, Andrews ZB, Du H, Elsworth JD, Taylor HS. Endometrial stem cell transplantation restores dopamine production in a Parkinson\u2019s disease model. J Cell Mol Med. 2011;15(4):747\u201355. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01068.x.","journal-title":"J Cell Mol Med."},{"issue":"9","key":"3264_CR186","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.5966\/sctm.2015-0023","volume":"4","author":"S Cerri","year":"2015","unstructured":"Cerri S, Greco R, Levandis G, Ghezzi C, Mangione AS, Fuzzati-Armentero M-T, Bonizzi A, Avanzini MA, Maccario R, Blandini F. Intracarotid infusion of mesenchymal stem cells in an animal model of parkinson\u2019s disease, focusing on cell distribution and neuroprotective and behavioral efects. Stem Cells Transl Med. 2015;4(9):1073\u201385.","journal-title":"Stem Cells Transl Med."},{"issue":"1","key":"3264_CR187","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/jcmm.12433","volume":"19","author":"EF Wolff","year":"2015","unstructured":"Wolff EF, Mutlu L, Massasa EE, Elsworth JD, Eugene Redmond D, Jr Taylor HS. Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson\u2019s disease. J Cell Mol Med. 2015;19(1):249\u201356. https:\/\/doi.org\/10.1111\/jcmm.12433.","journal-title":"J Cell Mol Med."},{"issue":"5","key":"3264_CR188","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00330-014-3549-3","volume":"25","author":"BN Park","year":"2015","unstructured":"Park BN, Kim JH, Lee K, Park SH, An YS. Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson\u2019s disease: small animal positron emission tomography study with F-18 FP-CIT. Eur Radiol. 2015;25(5):1487\u201396. https:\/\/doi.org\/10.1007\/s00330-014-3549-3.","journal-title":"Eur Radiol."},{"issue":"3","key":"3264_CR189","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3892\/etm.2017.4073","volume":"13","author":"M Salama","year":"2017","unstructured":"Salama M, Sobh M, Emam M, Abdalla A, Sabry D, El-Gamal M, Lotfy A, El-Husseiny M, Sobh M, Shalash A. Efect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson\u2019s disease. Exp Ther Med. 2017;13(3):976\u201382.","journal-title":"Exp Ther Med."},{"issue":"3","key":"3264_CR190","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/jnr.23879","volume":"95","author":"D Chen","year":"2017","unstructured":"Chen D, Fu W, Zhuang W, Lv C, Li F, Wang X. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson\u2019s disease. J Neurosci Res. 2017;95(3):907\u201317. https:\/\/doi.org\/10.1002\/jnr.23879.","journal-title":"J Neurosci Res."},{"issue":"16","key":"3264_CR191","doi-asserted-by":"publisher","first-page":"16062","DOI":"10.18632\/aging.103477","volume":"12","author":"C Yang","year":"2020","unstructured":"Yang C, Qiu Y, Qing Y, Xu J, Dai W, Hu X, Wu X. Synergistic efect of electric stimulation and mesenchymal stem cells against Parkinson\u2019s disease. Aging. 2020;12(16):16062\u201371.","journal-title":"Aging."},{"issue":"2","key":"3264_CR192","doi-asserted-by":"publisher","first-page":"89","DOI":"10.29252\/ibj.24.2.89","volume":"24","author":"L Ghahari","year":"2020","unstructured":"Ghahari L, Safari M, Rahimi Jaberi K, Jafari B, Safari K, Madadian M. Mesenchymal stem cells with granulocyte colony-stimulating factor reduce stress oxidative factors in Parkinson\u2019s disease. Iran Biomed J. 2020;24(2):89\u201398.","journal-title":"Iran Biomed J."},{"key":"3264_CR193","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms21218129","volume":"21","author":"H Park","year":"2020","unstructured":"Park H, Chang KA. Therapeutic potential of repeated intravenous transplantation of human adipose-derived stem cells in subchronic MPTP-induced Parkinson\u2019s disease mouse model. Int J Mol Sci. 2020;21:21.","journal-title":"Int J Mol Sci."},{"key":"3264_CR194","doi-asserted-by":"crossref","unstructured":"Jalali MS, Sarkaki A, Farbood Y, Azandeh SS, Mansouri E, Ghasemi Dehcheshmeh M, Saki G. Transplanted Wharton\u2019s jelly mesenchymal stem cells improve memory and brain hippocampal electrophysiology in rat model of Parkinson\u2019s disease. J Chem Neuroanat. 2020;110.","DOI":"10.1016\/j.jchemneu.2020.101865"},{"issue":"3","key":"3264_CR195","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3233\/JAD-170848","volume":"61","author":"SS Wang","year":"2018","unstructured":"Wang SS, Jia J, Wang Z. Mesenchymal Stem Cell-Derived Extracellular Vesicles Suppresses iNOS Expression and Ameliorates Neural Impairment in Alzheimer\u2019s Disease Mice. J Alzheimers Dis. 2018;61(3):1005\u201313. https:\/\/doi.org\/10.3233\/JAD-170848.","journal-title":"J Alzheimers Dis."},{"issue":"2","key":"3264_CR196","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1096\/fj.201700600R","volume":"32","author":"GH Cui","year":"2018","unstructured":"Cui GH, Wu J, Mou FF, Xie WH, Wang FB, Wang QL, Fang J, Xu YW, Dong YR, Liu JR, Guo HD. Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP\/PS1 mice. FASEB J. 2018;32(2):654\u201368. https:\/\/doi.org\/10.1096\/fj.201700600R.","journal-title":"FASEB J."},{"issue":"11","key":"3264_CR197","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s11064-018-2641-5","volume":"43","author":"M Ding","year":"2018","unstructured":"Ding M, Shen Y, Wang P, Xie Z, Xu S, Zhu Z, Wang Y, Lyu Y, Wang D, Xu L, Bi J, Yang H. Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer\u2019s Disease. Neurochem Res. 2018;43(11):2165\u201377. https:\/\/doi.org\/10.1007\/s11064-018-2641-5.","journal-title":"Neurochem Res."},{"key":"3264_CR198","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/cells8091059","volume":"8","author":"CA Elia","year":"2019","unstructured":"Elia CA, Tamborini M, Rasile M, Desiato G, Marchetti S, Swuec P, Mazzitelli S, Clemente F, Anselmo A, Matteoli M, et al. Intracerebral Injection of Extracellular Vesicles from Mesenchymal Stem Cells Exerts Reduced A\u03b2 Plaque Burden in Early Stages of a Preclinical Model of Alzheimer\u2019s Disease. Cells. 2019;8:1059.","journal-title":"Cells"},{"key":"3264_CR199","first-page":"1965","volume":"32","author":"W Zhao","year":"2019","unstructured":"Zhao W, Zhang H, Yan J, Ma X. An experimental study on the treatment of diabetes-induced cognitive disorder mice model with exosomes deriving from mesenchymal stem cells (MSCs). Pak J Pharm Sci. 2019;32:1965\u201370.","journal-title":"Pak J Pharm Sci"},{"key":"3264_CR200","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4103\/1673-5374.255978","volume":"14","author":"EE Reza-Zaldivar","year":"2019","unstructured":"Reza-Zaldivar EE, Hern\u00e1ndez-Sapi\u00e9ns MA, Guti\u00e9rrez-Mercado YK, Sandoval-\u00c1vila S, Gomez-Pinedo U, M\u00e1rquezAguirre AL, V\u00e1zquez-M\u00e9ndez E, Padilla-Camberos E, Canales-Aguirre AA. Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer\u2019s disease. Neural Regen Res. 2019;14:1626\u201334.","journal-title":"Neural. Regen Res."},{"key":"3264_CR201","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4103\/1673-5374.255978","volume":"14","author":"EE Reza-Zaldivar","year":"2019","unstructured":"Reza-Zaldivar EE, Hern\u00e1ndez-Sapi\u00e9ns MA, Guti\u00e9rrez-Mercado YK, Sandoval-\u00c1vila S, Gomez-Pinedo U, M\u00e1rquez-Aguirre AL, V\u00e1zquez-M\u00e9ndez E, Padilla-Camberos E, Canales-Aguirre AA. Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer\u2019s disease. Neural Regen Res. 2019;14:1626\u201334.","journal-title":"Neural Regen. Res."},{"issue":"4","key":"3264_CR202","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/cbin.11522","volume":"45","author":"X Wang","year":"2021","unstructured":"Wang X, Yang G. Bone marrow mesenchymal stem cells-derived exosomes reduce A\u03b2 deposition and improve cognitive function recovery in mice with Alzheimer\u2019s disease by activating sphingosine kinase\/sphingosine-1-phosphate signaling pathway. Cell Biol Int. 2021;45(4):775\u201384. https:\/\/doi.org\/10.1002\/cbin.11522.","journal-title":"Cell Biol Int."},{"key":"3264_CR203","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jconrel.2020.09.019","volume":"327","author":"X Ma","year":"2020","unstructured":"Ma X, Huang M, Zheng M, Dai C, Song Q, Zhang Q, Li Q, Gu X, Chen H, Jiang G, et al. ADSCs-derived extracellular vesicles alleviate neuronal damage, promote neurogenesis and rescue memory loss in mice with Alzheimer\u2019s disease. J Control Release. 2020;327:688\u2013702.","journal-title":"J Control Release"},{"issue":"9","key":"3264_CR204","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/sctm.19-0327","volume":"9","author":"M Losurdo","year":"2020","unstructured":"Losurdo M, Pedrazzoli M, D\u2019Agostino C, et al. Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer\u2019s disease. STEM CELLS Trans Med. 2020;9(9):1068\u201384.","journal-title":"STEM CELLS Trans Med"},{"key":"3264_CR205","doi-asserted-by":"crossref","unstructured":"Hassan R, Rabea AA, Ragae A, Sabry D. The prospective role of mesenchymal stem cells exosomes on circumvallate taste buds in induced Alzheimer\u2019s disease of ovariectomized albino rats: (Light and transmission electron microscopic study). Arch Oral Biol. 2020;110.","DOI":"10.1016\/j.archoralbio.2019.104596"},{"key":"3264_CR206","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.intimp.2018.12.001","volume":"67","author":"Z Li","year":"2019","unstructured":"Li Z, Liu F, He X, Yang X, Shan F, Feng J. Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int Immunopharmacol. 2019;67:268\u201380.","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"3264_CR207","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1021\/acsnano.9b01004","volume":"13","author":"M Riazifar","year":"2019","unstructured":"Riazifar M, Mohammadi MR, Pone EJ, Yeri A, L\u00e4sser C, Segaliny AI, McIntyre LL, Shelke GV, Hutchins E, Hamamoto A, Calle EN, Crescitelli R, Liao W, Pham V, Yin Y, Jayaraman J, Lakey JRT, Walsh CM, Van Keuren-Jensen K, Lotvall J, Zhao W. Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders. ACS Nano. 2019;13(6):6670\u201388. https:\/\/doi.org\/10.1021\/acsnano.9b01004.","journal-title":"ACS Nano."},{"issue":"2","key":"3264_CR208","doi-asserted-by":"publisher","first-page":"634","DOI":"10.5966\/sctm.2016-0071","volume":"6","author":"FG Teixeira","year":"2017","unstructured":"Teixeira FG, Carvalho MM, Panchalingam KM, Rodrigues AJ, Mendes-Pinheiro B, Anjo S, Manadas B, Behie LA, Sousa N, Salgado AJ. Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson\u2019s disease. Stem Cells Transl Med. 2017;6(2):634\u201346.","journal-title":"Stem Cells Transl Med."},{"key":"3264_CR209","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejpb.2017.09.014","volume":"121","author":"A Chierchia","year":"2017","unstructured":"Chierchia A, Chirico N, Boeri L, Raimondi I, Riva GA, Raimondi MT, Tunesi M, Giordano C, Forloni G, Albani D. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson\u2019s disease related toxin 6-hydroxydopamine. Eur J Pharma Biopharm. 2017;121:113\u201320.","journal-title":"Eur J Pharma Biopharm."},{"key":"3264_CR210","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fbioe.2019.00294","volume":"7","author":"B Mendes-Pinheiro","year":"2019","unstructured":"Mendes-Pinheiro B, Anjo SI, Manadas B, Da Silva JD, Marote A, Behie LA, Teixeira FG, Salgado AJ. Bone marrow mesenchymal stem cells\u2019 secretome exerts neuroprotective efects in a Parkinson\u2019s disease rat model. Front Bioeng Biotechnol. 2019;7:294.","journal-title":"Front Bioeng Biotechnol."},{"issue":"2","key":"3264_CR211","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/jcmm.14113","volume":"23","author":"C Giamp\u00e0","year":"2019","unstructured":"Giamp\u00e0 C, Alvino A, Magatti M, Silini AR, Cardinale A, Paldino E, Fusco FR, Parolini O. Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor defcits in the R6\/2 mouse model of Huntington\u2019s disease. J Cell Mol Med. 2019;23(2):1581\u201392.","journal-title":"J Cell Mol Med."},{"key":"3264_CR212","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","volume":"11","author":"HX Chen","year":"2020","unstructured":"Chen HX, Liang FC, Gu P, Xu BL, Xu HJ, Wang WT, Hou JY, Xie DX, Chai XQ, An SJ. Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy. Cell Death Dis. 2020;11:288.","journal-title":"Cell Death Dis."},{"issue":"2","key":"3264_CR213","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/cells9020315","volume":"9","author":"FG Teixeira","year":"2020","unstructured":"Teixeira FG, Vila\u00e7a-Faria H, Domingues AV, Campos J, Salgado AJ. Preclinical comparison of stem cells secretome and levodopa application in a 6-hydroxydopamine rat model of Parkinson\u2019s disease. Cells. 2020;9(2):315.","journal-title":"Cells."},{"key":"3264_CR214","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.omtn.2021.01.022","volume":"23","author":"Q Li","year":"2021","unstructured":"Li Q, Wang Z, Xing H, Wang Y, Guo Y. Exosomes derived from miR-188-3p-modifed adipose-derived mesenchymal stem cells protect Parkinson\u2019s disease. Mol Ther Nucleic Acids. 2021;23:1334\u201344.","journal-title":"Mol Ther Nucleic Acids."},{"issue":"5","key":"3264_CR215","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.14336\/AD.2020.1221","volume":"12","author":"C Xue","year":"2021","unstructured":"Xue C, Li X, Ba L, Zhang M, Yang Y, Gao Y, Sun Z, Han Q, Zhao RC. MSC-derived exosomes can enhance the angiogenesis of human brain MECs and show therapeutic potential in a mouse model of Parkinson\u2019s disease. Aging Dis. 2021;12(5):1211\u201322.","journal-title":"Aging Dis."},{"issue":"10","key":"3264_CR216","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jcyt.2021.04.002","volume":"23","author":"CR Marques","year":"2021","unstructured":"Marques CR, Pereira-Sousa J, Teixeira FG, Sousa RA, Teixeira-Castro A, Salgado AJ. Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson\u2019s disease. Cytotherapy. 2021;23(10):894\u2013901.","journal-title":"Cytotherapy."},{"key":"3264_CR217","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphar.2016.00231","volume":"7","author":"A Marote","year":"2016","unstructured":"Marote A, Teixeira FG, Mendes-Pinheiro B, Salgado AJ. MSCs-Derived Exosomes: Cell-Secreted Nanovesicles with Regenerative Potential. Front Pharmacol. 2016;7:231.","journal-title":"Front Pharmacol."},{"key":"3264_CR218","doi-asserted-by":"crossref","unstructured":"Chaput N, Th\u00e9ry C. Exosomes: immune properties and potential clinical implementations. In Seminars in immunopathology, vol. 33. 2011; Springer-Verlag, pp. 419\u201340","DOI":"10.1007\/s00281-010-0233-9"},{"issue":"12","key":"3264_CR219","doi-asserted-by":"publisher","first-page":"8157","DOI":"10.1007\/s12035-019-01663-0","volume":"56","author":"AM Gorabi","year":"2019","unstructured":"Gorabi AM, Kiaie N, Barreto GE, Read MI, Tafti HA, Sahebkar A. The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Treatment of Neurodegenerative Diseases. Mol Neurobiol. 2019;56(12):8157\u201367.","journal-title":"Mol Neurobiol."},{"key":"3264_CR220","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5772\/61186","volume":"4","author":"KJ McKelvey","year":"2015","unstructured":"McKelvey KJ, Powell KL, Ashton AW, Morris JM, McCracken SA. Exosomes: Mechanisms of Uptake. J Circ Biomark. 2015;4:7.","journal-title":"J Circ Biomark."},{"issue":"3","key":"3264_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt213","volume":"4","author":"Q Li","year":"2013","unstructured":"Li Q, Wang Y, Deng Z. Pre-conditioned mesenchymal stem cells: a better way for cell-based therapy. Stem Cell Res Ther. 2013;4(3):1\u20133.","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"3264_CR222","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13287-017-0531-4","volume":"8","author":"E Redondo-Castro","year":"2017","unstructured":"Redondo-Castro E, Cunningham C, Miller J, Martuscelli L, Aoulad-Ali S, Rothwell NJ, Kielty CM, Allan SM, Pinteaux E. Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro. Stem Cell Res Ther. 2017;8(1):79.","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"3264_CR223","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s11658-022-00359-z","volume":"27","author":"M Rahbaran","year":"2022","unstructured":"Rahbaran M, Zekiy AO, Bahramali M, Jahangir M, Mardasi M, Sakhaei D, Thangavelu L, Shomali N, Zamani M, Mohammadi A, Rahnama N. Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects. Cell Mol Biol Lett. 2022;27(1):56. https:\/\/doi.org\/10.1186\/s11658-022-00359-z.","journal-title":"Cell Mol Biol Lett."},{"key":"3264_CR224","doi-asserted-by":"publisher","first-page":"27791","DOI":"10.1038\/srep27791","volume":"6","author":"FG Teixeira","year":"2016","unstructured":"Teixeira FG, Panchalingam KM, Assun\u00e7\u00e3o-Silva R, Serra SC, Mendes-Pinheiro B, Patr\u00edcio P, Jung S, Anjo SI, Manadas B, Pinto L, Sousa N, Behie LA, Salgado AJ. Modulation of the Mesenchymal Stem Cell Secretome Using Computer-Controlled Bioreactors: Impact on Neuronal Cell Proliferation. Survival and Differentiation Sci Rep. 2016;6:27791. https:\/\/doi.org\/10.1038\/srep27791.","journal-title":"Survival and Differentiation. Sci Rep."},{"issue":"1","key":"3264_CR225","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13287-015-0124-z","volume":"6","author":"FG Teixeira","year":"2015","unstructured":"Teixeira FG, Panchalingam KM, Anjo SI, Manadas B, Pereira R, Sousa N, Salgado AJ, Behie LA. Do hypoxia\/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome? Stem Cell Res Ther. 2015;6(1):133. https:\/\/doi.org\/10.1186\/s13287-015-0124-z.","journal-title":"Stem Cell Res Ther."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03264-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03264-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03264-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T22:24:38Z","timestamp":1702333478000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03264-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":225,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3264"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03264-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]},"assertion":[{"value":"19 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}